Peptone

Designing novel therapeutics against previously undruggable targets using experimental and computational biophysics.

Sector

Life Sciences

Category

AI
Therapeutics

Status

Private

Location

London, UK

Initial Investment

2022
Designing novel therapeutics against previously undruggable targets using experimental and computational biophysics.

Peptone is an innovative drug discovery company applying advanced biophysics, atomic-level experimental approaches, cutting-edge supercomputing and machine learning to the challenge of biopharmaceutical research and development. By bringing these proprietary approaches together, Peptone is exploring the world of intrinsically disordered proteins (IDPs) – proteins without a fixed structure that play a significant role in health and disease – opening up the possibility of novel therapeutics against this class of high value and previously undruggable targets.